Stay updated on Gantenerumab in Early Alzheimer's Disease Clinical Trial

Sign up to get notified when there's something new on the Gantenerumab in Early Alzheimer's Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gantenerumab in Early Alzheimer's Disease Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a versioning label with no change to study details or page functionality.
    Difference
    0.0%
    Check dated 2026-03-06T18:00:19.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    Minor backend/UI update from v3.4.1 to v3.4.2 with no changes to study data or core content. The page presentation and information remain the same for users. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T01:25:03.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Website version updated from v3.4.0 to v3.4.1; no user-facing content changes detected.
    Difference
    0.0%
    Check dated 2026-02-05T12:59:36.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Show glossary is now displayed by default, and the page includes updated QC and policy labels: 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'. The release has been updated to version 3.4.0, replacing 3.3.4.
    Difference
    0.1%
    Check dated 2026-01-29T06:27:34.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 with no changes to core content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T03:01:08.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Expanded the Locations section with numerous new study sites across the US, Canada, Australia, Europe, and other regions, and removed several previous location blocks.
    Difference
    2%
    Check dated 2025-12-24T15:25:19.000Z thumbnail image

Stay in the know with updates to Gantenerumab in Early Alzheimer's Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gantenerumab in Early Alzheimer's Disease Clinical Trial page.